Will Doximity (DOCS) stock recover?
What do analysts say about DOCS?
Average price target from 18 analysts: $27 over ~12 months (Hold consensus), i.e. +4 % from the current price. Most reliable firm on DOCS: Barclays (50% hit rate, 2 scored calls). A target is a 12-month view, not for tomorrow.
What happened after its past drops?
Doximity has only had 2 drops of 30%+ over 2021-2026 — too few to draw a reliable trend. (monthly history 2021-2026 — transparency data, not a guarantee)
DOCS's biggest months
⚠️ Drop measured from the 12-month high; analyst targets on a ~12-month horizon; monthly history since 2013. Information, not investment advice. Past performance does not guarantee future results.
Frequently asked questions
Will Doximity stock recover?
No one can guarantee it, and we won't. What we know: it's down 71 % from its high; analysts target $27 over 12 months (+4 % from the current price). Doximity has only had 2 drops of 30%+ over 2021-2026 — too few to draw a reliable trend. Past performance does not guarantee future results.
Why has DOCS dropped so much?
We don't assert the cause of a drop — a headline can be a consequence or a coincidence. What we measure is what comes next: the analysts' target and the stock's historical behavior after this kind of drop.
Should I buy DOCS now that it's down?
A drop is not a buy signal by itself. Cross-check with the analysts' target, their real reliability on the stock (most solid: Barclays, 50% hit rate), and the fundamentals. This is not personalized advice.